National Viral Hepatitis Prevention Conference
December 2005 - Washington D.C.
Please
note that the following information was current at the time of
the meeting. Use caution when using these resources as some of this
information may have changed.
In the agenda summary below, click on a date or title to jump to the corresponding location on the page.
Perinatal B Coordinators
Hepatitis C Coordinators
Indian Health Service
Hepatitis 101
National Nurses Advisory Council
Opening Plenary (summary only)
Monday, Dec 5
9:00 AM-2:30 PMHepatitis B Coordinators (Update) [PDF - 16 pages]
Hepatitis C Coordinators
Indian Health Service
Hepatitis 101: Introduction to Hepatitis A-E [PDF - 97 pages]
Summary: This workshop will be provide an overview of viral Hepatitis A, B, C, D, and E, including basic epidemiology, risk factors, and prevention measures. This is designed for people new to the field of viral hepatitis, but will also serve as a good review for people who already work in viral hepatitis prevention and control.
Moderator: Joanna Buffington; DVH, CDC
PL1 - Opening Plenary: Overview of a National Viral Hepatitis Prevention Strategy
Summary: This opening plenary will welcome participants to the conference and specifically to Washington D.C., and give an overview of the week’s agenda. The Director of DVH will present an overview of national hepatitis strategies for prevention, and set the tone for the entire meeting. Finally, a person living with chronic hepatitis will share a personal perspective.
Moderator: Joanna Buffington; DVH, CDC
Overview of a National Viral Hepatitis Prevention Strategy John Ward, Director, DVH, CDC
Chronic Viral Hepatitis: A Personal Perspective Ray Benson, Lead Singer, Asleep At the Wheel
Tuesday, Dec 6
8:30 AM-10:00 AMPL2 - Adolescent and Adult Hepatitis Vaccination Update [PDF - 78 pages]
Summary: This plenary will update participants on the current state of Hepatitis A and Hepatitis B vaccination among adolescents and adults at behavioral risk for these infections. It will include updates on the importance of considering these immunizations alongside other prevention activities for persons at risk for sexually transmitted diseases, the progress of the pending CDC/ACIP recommendations for adult Hepatitis B immunization, and the burgeoning CDC collaborative initiative to prevent Hepatitis B among adults
Moderator: John Douglas; Director, Division of STD Prevention, CDC
Critique of
Hepatitis B vaccination as an interdisciplinary model for preventing
sexually transmitted infections [PDF - 46 pages]
King Holmes, Center for AIDS and STD, University of Washington
What changes
are new ACIP adult Hepatitis B guidelines going to make? [PDF - 36 pages]
Cindy Weinbaum, DVH, CDC
A1 - High Risk Adolescent Hepatitis Prevention
Summary: Providing hepatitis prevention for at risk adolescents; collaboration with schools, local government, and at-risk populations.
Moderator: John C. Canfield; Division of Adolescent and School Health, CDC
Annual Youth Leadership
Conference on Asian and Pacific Islander Health [PDF - 33 pages]
(1)
Eric Sue; BS; Stanford University
The State
of Connecticut Department Viral Hepatitis Prevention in the Adolescent
Population [PDF - 34 pages]
(2)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of
Public Health
Hepatitis B
and Washington State Asian/Pacific Islander (API) Teens, Strenthening
Linkages for Student Success [PDF - 23 pages]
(3)
Shana Johnny; RN, MN; Washington State Department of Health
A2 - Training for Viral Hepatitis Integration
Summary: A snapshot of two federally-funded training programs that focus on hepatitis integration in various settings; discussion of skills needed to facilitate successful integration training
HCV Integration into the Diffusion of Evidence Based Interventions
(DEBI’s) [PDF - 7 pages]
Moderator: Ann Shindo; Hepatitis C Coordinator, Oregon Dept. of
Human Services
Enhancing Viral
Hepatitis Presentations and Trainings [PDF - 16 pages]
(4)
Heather Lusk; BA/BS; Hawai`i Department of Health
Integrating
Viral Hepatitis into Client Centered Counseling [PDF - 18 pages]
(5)
Dana Cropper-Williams; MPA, MHR; National Coalition of STD Directors
It’s Time
to Integrate Viral Hepatitis Education and Training into HIV, STD,
Corrections, and Substance Abuse Settings [PDF - 21 pages]
Richard Controneo, Nat'l. Viral Hepatitis Education & Training Center,
NY State Dept. of Health
A3 - Vaccination Strategies for Injection Drug Users
Summary: This workshop will focus on how to incorporate vaccination strategies into syringe exchange programs, serving injection drug users (IDUs).
Moderator: Jeff Rothman; AIDS Institute, NY State Dept. of Health
Adherence to Hepatitis B Virus Vaccination at Syringe Exchange
Sites (6)
Frederick L. Altice; MD; Yale University
Buprenorphine Treatment On-Site Proximate to Syringe Exchange
Sites As a Way to Increase Hepatitis B Vaccination (7)
Robert D. Bruce; MD, MA; Yale University
Developing a New Vaccination Strategy for Injection Drug Users
(8)
Dan Bigg; BA, CRADC; Chicago Recovery Alliance
A4 - Community-Based Integration Models
Summary: This workshop will focus on integrating hepatitis prevention services, including education and vaccination, into community-based health clinics and programs. Presentations will include experience targeting high risk adolescents and adults who are seen in a variety of community-based settings, both clinical and non-clinical, in North Carolina, Miami, FL, and Washington, D.C.
Moderator: Bayo C. Willis; Centers for Disease Control and Prevention
Overcoming
Barriers When Integrating Hepatitis Vaccine into Established Community
Organizations [PDF - 12 pages]
(9)
Susan Thompson; RN, BA, MPH; North Carolina Department of Public
Health
Hepatitis B Testing & Vaccination in a Community-Based Clinic [PDF - 23 pages]
(10)
Luis I. García; MS; Whitman-Walker Clinic
Lori S. Jordahl; MBA-HA; Miami Dade County Health Department
A5 - Hepatitis Vaccines: Making It a Reality in STD Clinics
Summary: This workshop will focus on experience integrating hepatitis vaccination (both A and B) into STD clinic settings. Presentations will include determining the cost effectiveness of blood testing for immunity prior to Hepatitis B vaccination, initiating a new vaccine program, and implementing a statewide vaccine program for STD clinics.
Moderator: Deymon Fleming; National Center for HIV, STD & TB Prevention, CDC
The Cost Effectiveness of Determining Hepatitis Prevalence Prior
to Immunization in an Urban STD Clinic (12)
Shukdeo Sankar; MD; District of Columbia Government
Initiation of Adult Hepatitis B and A/B Vaccine Program at a
Sexually Transmitted Disease Clinic (13)
Pamela J. Wall; PA/C; Marion County Health Department
Cheryl V. Pearcy; BS; Indiana State Department of Health
A6 - Viral Hepatitis Surveillance
Summary: Surveillance for acute and chronic viral hepatitis is critical for local, state, and national health officials to follow trends in viral hepatitis infections, identify possible outbreaks, and to help determine the burden of infection and disease so as to best target prevention efforts, research, and public health resources. This workshop will provide an overview of national surveillance for acute and chronic Hepatitis C, a state perspective on HCV surveillance and NYC experience with acute Hepatitis B surveillance.
Moderator: Lyn Finelli; DVH, CDC
New Directions
in Hepatitis C Virus Surveillance [PDF - 27 pages]
Lyn Finelli
HCV Surveillance:
Connecticut's Experience in System Development [PDF - 16 pages]
(15)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of
Public Health
Surveillance for Acute Hepatitis B in New York City, 2004 [PDF - 20 pages]
(16)
Katherine Bornschlegel; MPH; New York City Dept of Health and Mental
Hygiene
B1 - Adolescent Hepatitis Prevention via Education and Vaccination
Summary: This workshop will include information and experience on how to work with school programs, and preventing hepatitis by the use of "Liver Wellness" education for all, vaccination for high-risk adolescents, and bridging their barriers
Moderator: Dielda Robertson; Hepatitis C Coordinator, Louisiana Office of Public Health
How schools work, and how to work with schools - James Bogden, Project Director, Safe and Healthy School Project, Nat’l Assoc. of State Boards of Education
Administration of Hepatitis Vaccination Series to At-Risk Teens
in the Public Health Setting, Vanderburgh County, Indiana, United
States, 2005 (17)
Kelly N. Kelley; BSN, MA; Vanderburgh County Department of Health
Liver Wellness - An Effective Approach to Promoting Prevention
of Viral Hepatitis (18)
Thelma King Thiel; RN, BA; Hepatitis Foundation International
B2 - Hepatitis Prevention Campaigns for Men Who Have Sex With Men
Summary: This session will highlight social marketing campaigns for MSM and discuss data from studies that may inform future marketing and intervention campaigns for MSM.
Moderator: Harold S. Levine; Principal, Levine & Co
Hepatitis Social
Marketing Campaign in San Diego [PDF - 26 pages]
(19)
Deborah S. Brown; MBA; Family Health Centers of San Diego
Hepatitis
A and Hepatitis B Vaccination Campaign Preferences Among Men Who
Have Sex With Men [PDF - 24 pages]
(MSM) (20)
Rachele Peterson; BA; American Social Health Association
Hepatitis
A and B vaccination perceptions among men who have sex with men [PDF - 24 pages]
(MSM) (21)
Rachele Peterson; BA; American Social Health Association
B3 - Chronic Hepatitis B and C: Treatment Update
Summary: In this session, an overview of currently available recommended options for treatment of chronic Hepatitis B and C will be presented, along with latest research data on side effects and effectiveness of these treatments. Additional treatments currently under research will also be shared. Discussion will include various options for accessing treatment currently available.
Moderator: Miriam Alter; Associate Director for Science, DVH, CDC
Chronic Hepatitis
B & C: Treatment Update [PDF - 43 pages]
Michael Fried, Professor of Medicine, Director of Hepatology, University
of N.C.
B4 - Enhancing Hepatitis C Prevention in Syringe Exchange Programs
Summary: This session will provide two examples of involving academic institutions in Hepatitis C prevention activities that take place as part of syringe exchange programs. The advantages being (1) providing medical attention to underserved groups, (2) adding practical experience to an academic curriculum, and (3) saving valuable program monies.
Corrections:
The Next Challenge for Harm Reduction
In the U.S. [PDF - 36 pages]
Moderator: Bruce Trigg; Medical Director, STD Program, New Mexico
Dept. of Health
Hepatitis C Prevention in IVDUs: The Intersection of the Harm
Reduction and Medical Models (22)
Serena Lauren Roth; BS; New York University School of Medicine
Paul Izak Campion; New York University School of Medicine
Implementing Viral Hepatitis Services in a Mobile Needle Exchange
Program (23)
Catherine A. O'Connor; HIV Innovations/Northeastern University
B5 - Viral Hepatitis Transmission in Health Care Settings: Strategies for Prevention and Control
Summary: Transmission of viral hepatitis in ambulatory care, long-term care and other settings is increasingly recognized. Outbreaks have affected hundreds of patients, and investigations are disruptive and resource intensive. This session will highlight key findings from recent outbreaks and present strategies to improve our ability to detect transmission and protect patients.
Moderator: Valerie Curry; DVH, CDC
Recent Outbreaks: Key Findings and Common Theme
Joseph Perz, DVH, CDC
Working with Partners to Achieve Early Detection and Primary
Prevention
Ian Williams, DVH, CDC
B6 - Viral Hepatitis Policy: Challenges and Opportunities
Summary: There are major gaps in programs and support for viral hepatitis prevention services in the United States. This workshop will include updates from the National Viral Hepatitis Roundtable and other partners working to fill these gaps and promote viral hepatitis prevention support and programs at multiple levels.
Moderator: Deborah Wexler; Executive Director, Immunization Action Coalition
National
Viral Hepatitis Elimination Strategy [PDF - 12 pages]
(24)
Marie P. Bresnahan; MPH; American Liver Foundation
Advancing National
Viral Hepatitis Policy: Challenges and Opportunities [PDF - 16 pages]
(25)
Laurie Schowalter; MPH; National Alliance of State and Territorial
AIDS Directors
Laura Hanen; BA, MPP; National Alliance of State and Territorial
AIDS Directors
Poster Session #1
The Rate of Serum HbsAg and HbsAB Among Korean Americans (26)
Dr. Haoek Lee; Univ. of Colorado School of Nursing
Using the Church as a Non-Traditional Setting for HBV Vaccination
(27)
Dr. Haoek Lee; Univ. of Colorado School of Nursing
Hepatitis B-Related Mortality in the United States, 1990-2001:
Analysis of Multiple Cause-Coded Death Data (28)
Helen W. Shih; BA, MPH; Los Angeles County Department of Health
Services
Integrating Hepatitis Prevention Into Existing School Health
Programs (29)
Kathryn L. White; MT, RN, BSN; Nebraska HHSS
Viral Hepatitis Resource Kits for Public Health Organizations
(30)
Kathryn L. White; MT, RN, BSN; Nebraska HHSS
Prevalence of Hepatitis C Virus prevalence in United Arab Emirates
(UAE) (31)
G.M. Monawar Hosain; MBBS, MSc, PhD
A Method for Developing and Evaluating an Integrated Risk Questionnaire
(32)
Colleen A. Flanigan; RN, MS; NYS Department of Health
Hep Team Chicago: A Knock-Out MSM Program (33)
Harold S. Levine; BA; Levine & Partners, Inc
Integrating the Hepatitis Adolescent Program to Already Existing
Youth Services (34)
Claudia Patricia Teran; Dr; University of Miami
Hospital Record Reviews: The Cornerstone of Continuous Quality Improvement
for Perinatal Hepatitis B Prevention in NYS (35)
Elizabeth Herlihy; BSN, MS; NYS Department of Health
Epidemiological Aspects of Hepatitis C Virus Infection Among Pregnant Women
and Neonates in Al-Ain Medical District in the United Arab Emirates
(36)
S.A. Uduman; Preventive Medicine Al-Ain (UAE)
Vaccines for Adults at High Risk - Kansas (37)
Kathleen Waters; BA; Kansas Department of Health and Environment
Viral Hepatitis: Stigmatization of Adults and Children (38)
William M. Remak; B, Sc, MT, BA, Public, He; National Association
of Hepatitis Task Forces
Integrating Viral Hepatitis into Counseling: Preliminary Results
(39)
Heather Lusk; BA/BS; Hawai`i Department of Health
Massachusetts Birth Hospital Hep B and Rubella Chart Review (40)
Martha Badger; RN, BSN; Massachusetts Department of Public Health
Resources for Providers for Hepatitis B Vaccination in Alternative
Settings (41)
Deborah L. Wexler; MD; Immunization Action Coalition
Building a Multi-Tiered Outreach, Education and Training Campaign
for the Prevention of Hepatitis B: A Model for Success (42)
Molli Conti; Hepatitis B Foundation
Integrating Hepatitis B Education into Welfare-to-Work Programs:
Results of a Pilot Study (43)
Fonta Reilly; BS; Hepatitis B Foundation
The "Safer Tattooing Practices Initiative" in the Correctional
Service of Canada (44)
Kazimiera Adamowski; BA, MSW; Public Health Agency of Canada
Cultural Competency for Public Health Professionals (45)
Bruce Heath; BA; CDC
Bringing it all Together: Indiana's Viral Hepatitis Working Group
(46)
Cheryl V. Pearcy; BS; Indiana State Department of Health
Department of Health and Community-Based Organization Collaboration in Viral
Hepatitis Prevention (47)
Kate Schneier; Health, Educator; New Mexico AIDS Services
Jimmy Schrock; BS, Psychology; New Mexico AIDS Services
State of Connecticut Department of Public Health Perinatal Hepatitis
B Case Management: The First Twelve Years – 1992 to 2003 (48)
Laura Diskavich; RN, BSN, MS, APRN, BC; State of Connecticut Department
of Public Health
Use of GIS to Track Hepatitis B and C Prevention Activities:
2002 to 2005, Where Have We Been? (49)
Suzanne Speers; BA, MPH, RHIA; State of Connecticut Department of
Public Health
Perinatal Hepatitis B Prevention: Case Management at the Local
Health Department Level (50)
Gretchen W. Alexander; BA, BSN; City of Columbus
The Hillsborough County Perinatal Hepatitis B Prevention Project
(51)
Elaine Thomas; BSP; Hillsborough County Health Department
Chicago's Birthing Hospitals Perinatal Hepatitis B Records Review
(52)
Patricia Hoskins-Saffold; RN, MSN; Chicago Department of Public
Health
Doors of Integration (53)
Judy Norton; BS, Health, Science; Arizona Department of Health Services
Assessment of Screening, Treatment and Prevention of Perinatal
Infections in the Philadelphia Birth Cohort (54)
Amy B. Jessop; PhD, MPH; HepTREC
Follow-up of False HBsAg Positive Cases in Pregnant Women Consumes
Valuable Resources (55)
Vickie J. Weeast; Colorado Department of Public Health and Environment
Hepatitis B Knowledge and Testing Practices Among Colorado Obstetric
Providers (56)
Vickie J. Weeast; Colorado Department of Public Health and Environment
Evaluating a National Viral Hepatitis Training Curriculum (57)
Rachel Iverson; MA; New York State Department of Health
Excess Mortality Associated with Chronic Hepatitis B Virus Infection:
The Risk Evaluation of Viral Load Elevation and Associated Liver
Disease/Cancer (58)
Uchenna H. Iloeje; MD, MPH, FACP; Bristol-Myers Squibb
Identifying Chronic Hepatitis B Infected Subjects at Risk of
Liver Cirrhosis: The Risk Evaluation of Viral Load Elevation and
Associated Liver Disease/Cancer (59)
Uchenna H. Iloeje; MD, MPH, FACP; Bristol-Myers Squibb
Assessing the Hepatitis-Related Educational Needs of Clinical
Care Providers (60)
Leigh Guarinello; MPH; Inova Health Systems
Elevated Serum Level of Hepatitis B Virus (HBV) DNA is an Independent
Risk Factor for Hepatocellular Carcinoma: The Risk Evaluation of
Viral Load Elevation and Associated Liver Disease/Cancer (THE R.E.V.E.A.L.-
HBV Study) (61)
Uchenna H. Iloeje; MD, MPH, FACP; Bristol-Myers Squibb
Government Working with Youth to Prevent Hepatitis: Model Development
and Best Practices (62)
Annie J. Lacoursiere; BA, Hon, Comms; Government of Canada
Integrating Hepatitis Prevention Messages into HIV Prevention
Services (63)
Sandra Van Sant; MPH, MN; NJDHSS
Florida Birthing Facilities' Hepatitis B Screening and Vaccination
Practices (64)
Laura A. Kearns; MPH; CDC, National Immunization Program
Closing the Gap on Adult Hepatitis Vaccination in New York State
(66)
Elizabeth Herlihy; RN, BSN, MS; New York State Department of Health
An Update of Washington State Perinatal Hepatitis B Program (67)
Shana Johnny; RN, MN; Washington State Department of Health
Claire Norby; Washington State Department of Health Hepatitis
Outreach for High-Risk Individuals in Vigo County, Indiana (68)
Carolyn LaMar; ANP; Vigo County
Bridging the Gap: Carver County, Minnesota's Hepatitis B Jail
Vaccination Program (69)
Cheri D. Reyes; MPH; Minnesota Department of Health Pauline Herrmann;
RN; Carver County
Developing a Comprehensive Community-Based Hepatitis B Prevention
Program: The Asian-American Hepatitis B Program in New York City
(70)
Thomas Tsang; MD, MPH; Charles B. Wang Community Health Center
Henry Pollack; MD; New York University School of Medicine
Screening Asian Immigrants for Hepatitis B: Does Previous Immunization
Count? (71)
Karen E. Kim; MD, MS; University of Chicago
Integration of Hepatitis C Counseling and Testing Services into
Public Health Settings in California (72)
Lori Fries; MPH; California Department of Health Services
C1 - Interpreting Basic Viral Hepatitis Serology [PDF - 53 pages]
Summary: This workshop will provide the attendee with basic viral hepatitis serologic profiles, interpretation of those profiles and case studies to apply that information. There will be ample time for question and answer periods during and at the end of the workshop.
Moderator/Presenter: Linda A. Moyer; DVH, CDC
Wednesday, Dec 7
8:30 AM-10:00 AMPL3 - Progress Toward Reducing Perinatal and Childhood Viral Hepatitis
Summary: This plenary will review the progress and next steps towards reducing perinatal and childhood Hepatitis B infections from national and local perspectives. Reduction of childhood Hepatitis A will be discussed through a review of Hepatitis A epidemiology and the rationale for routine childhood immunization.
Moderator: Nancy Fasano; National Immunization Program, CDC
Progress Towards
Elimination of Perinatal and Childhood Hepatitis B Infections [PDF - 38 pages]
Eric Mast, Chief, Prevention Branch, DVH, CDC
Implementing New Perinatal and Childhood Hepatitis B Recommendations:
A City Health Department Perspective [PDF - 27 pages]
Julie Morita, Medical Director, Immunization Program, Chicago Department
of Health
Beth Bell, Chief, Epidemiology Branch, DVH, CDC
D1 - Addressing the Challenges to Ensuring a Birth Dose of Hepatitis B Vaccine
Summary: Presentation on challenges to reinstating the birth dose of Hepatitis B vaccine followed by an expert panel discussion on overcoming barriers.
Moderator: Lisa Jacques-Carroll [PDF - 8 pages]; NIP, CDC
Challenges
to Reinstating the Hepatitis B Birth Dose in NYS [PDF - 18 pages]
(73)
Elizabeth Herlihy; RN, BSN, MS; New York State Department of Health
Expert Panel Discussion - Deborah Wexler (IAC) , Beverly Sheets (Indiana Dept. of Health), and Robert Frenck (UCLA School of Medicine and AAP)
D2 - Models for Reaching Out: Developing Culturally Competent Hepatitis Prevention Programs
Summary: This workshop will highlight program models that have proven successful in providing culturally competent viral hepatitis services to communities of color. Specific programs designed for Hispanic/Latinos, African Americans, and Asian Pacific Islanders will be presented and discussed.
Moderator: Marian McDonald; Associate Director for Minority & Womens' Health, NCID, CDC
Developing Culturally Responsive Prevention Strategies: Practices
and Challenges
Julio Dicent Taillepierre, NCHSTP, CDC
Working with Clinicians Serving Mobile and Latin American Immigrant
Populations to Prevent Hepatitis: the HepTalk Project [PDF - 17 pages]
(74)
Edward L. Zuroweste; MD; Migrant Clinicians Network
Hepatitis B Prevention & Education Symposium: Building Partnerships
with Traditional Chinese Medicine (TCM) Practitioners [PDF - 33 pages]
(75)
Eric Sue; BS; Stanford University
D3 - Hepatitis Infection in IDUs: Current Epidemiologic Trends
Summary: In this session, an overview of hepatitis epidemiology among IDUs will be shared, followed by results from research projects looking at Hepatitis A, B and C among IDUs. Risk behaviors and preventive care acceptance (e.g. vaccine) will be discussed.
Moderator: Ian T. Williams; DVH, CDC
Hepatitis A and B virus (HAV and HBV) seroprevalence and structural
factors associated with vaccine uptake among younger injection drug
users (IDUs) in 5 U.S. cities (76)
Cindy Weinbaum; MD, MPH; Centers for Disease Control and Prevention
Trends in Hepatitis
B and C Seroprevalence in Young Seattle-Area Injection Drug Users [PDF - 19 pages]
(77)
Richard Burt; PhD; Public Health - Seattle & King County
Awareness of Hepatitis C virus serostatus and risk behavior in
young injection drug users in 5 US cities (78)
Holly Hagan; MPH, PhD; National Development and Research Institutes
D4 - Integrating HCV Prevention in Substance Abuse Programs
Summary: This session presents examples of how Hepatitis C prevention and care activities were integrated into substance abuse programs by either directly providing services or improving access to care.
Moderator: Danni Lentine; National Center for HIV, STD & TB Prevention, CDC
Experience Integrating HCV Education and Treatment in Substance
Abuse Clinic [PDF - 24 pages]
(79)
Norah M. Sullivan; MSN; VA Puget Sound Health Care System
Integrating Hepatitis Counseling and Testing in Substance Abuse
Programs [PDF - 25 pages]
(80)
Barbara Rush; NA; The Center for Drug Free Living, Inc
National Forum on Crack Cocaine and Hepatitis C Virus (HCV) (81)
Tracey Donaldson; BA, MSW; Public Health Agency of Canada
D5 - Developing State and Local Partnerships
Summary: This workshop will explore collaborations and partnerships that are essential to the successful integration of viral hepatitis prevention education and services.
Moderator: Victoria Moody; DVH, CDC
The Florida
Hepatitis Collaboration, Assessment, Resources, and Education (FL
Hep-CARE) Project: Care and Treatment for Viral Hepatitis [PDF - 25 pages]
(82)
Caroline Rains; MD; Alachua County Department of Health
Community and
Public Health Partnerships for Planning and Implementation of Comprehensive
Hepatitis Prevention Services [PDF - 24 pages]
(83)
Eric Rude; MSW; New York City Department of Health and Mental Hygiene
Karen Gonzales; BA; New Mexico Department of Health
Ana "Bertie" Lozano; BA; Pima County Health Department
D6 - Hepatitis Prevention and Care in Corrections and Beyond...
Summary: This workshop will include experiences with hooking inmates who are started on treatment for Hepatitis C while in prison, to continued care when released, and experience vaccinating inmates in both jail and prison settings.
Moderator: Norm Fikes, National Center for HIV, STD and TB Prevention, CDC
Hepatitis C Treatment Continuity Program [PDF - 9 pages]
(84)
Lester N. Wright; MD, MPH; New York State Department of Correctional
Services
Adult Hepatitis A & B Immunization of Women at Cook County Jail,
Sheriff's Female Furlough Program (85)
Corinna Dan; RN; Chicago Department of Public Health
Implementing Routine Hepatitis B Vaccination in the Incarcerated
Setting [PDF - 24 pages]
(86)
Josiah D. Rich; MD, MPH; Brown University
E1 - Childhood Hepatitis A Epidemiology and Prevention
Summary: This workshop will cover epidemiology of Hepatitis A among children, and the impact of vaccination strategies from both the national and state perspective.
Moderator: Beth Bell; DVH, CDC
Modelling
Hepatitis A in the United States [PDF - 14 pages]
(87)
Companion to the slides [PDF - 4 pages]
Thierry Van Effelterre; PhD; GlaxoSmithKline Biologicals
Incidence
of Hepatitis A in Arizona after the Implementation of Vaccination
for Young Children [PDF - 27 pages]
(88)
Laura M. Erhart; MPH; Arizona Department of Health Services
E2 - Living With Hepatitis C: Getting the Information You Need
Summary: This workshop will explore issues related to living with HCV infection. Materials developed by the South Bronx Hepatitis C Task Force, and the Live Longer Project, an educational program for people living with Hepatitis C, will be described. There will be discussion of approaches to helping people with Hepatitis C access health and support services.
Moderator: Oksana Bilukha; DVH, CDC
How to Stay
Healthy and Informed: Resources from the South Bronx Hepatitis C
Task Force [PDF - 27 pages]
Eric Rude, Hepatitis C Coordinator, NYC Department of Health and
Mental Hygiene
The Live Longer
Project [PDF - 13 pages]
(89)
Judy Norton; BS, Health, Science; Arizona Department of Health Services
E3 - Immunization Registries: Use for Tracking Adolescent and Adult Immunizations
Summary: This workshop will explore the successes and barriers to implementing registries to track Hepatitis B vaccination of adolescents and adults, including completion of the vaccine series.
Moderator: Gary Urquhart [PDF - 12 pages]; National Immunization Program, CDC
Immunization
Registry Support for Prevention of Adolescent and Adult Hepatitis [PDF - 31 pages]
Karen White, Minnesota Immunization Information Connection, MN Dept.
of Health
Using Immunization Registries for Adult Vaccine Tracking: The
Washington, D.C. Experience
Rosie McClaren, Immunization Program Manager, Washington, D.C. Department
of Health
E4 - Comprehensive HCV Prevention and Care in Substance Abuse Programs
Summary: This session provides examples of comprehensive hepatitis prevention and care delivery models. One model provides a wide spectrum of services within a single facility which is familiar and acceptable to clients. The other provides comprehensive care by coordinating and integrating several drug treatment and primary care facilities to facilitate access to care.
SAMHSA Hepatitis A and B Vaccine Initiative [PDF - 12 pages]
Moderator: Robert Lubran; Substance Abuse and Mental Health
Services Admin
Implementing a Comprehensive Hepatitis C (HCV) Prevention
Program within a Residential Drug Treatment Program (90)
Marguerite Gebhardt; MPS, RN; Project Samaritan Health Services
A Model Program for Integrating Hepatitis C Management within
Opioid Treatment Programs (OTPs) (91)
Alain H. Litwin; MD, MPH; Albert Einstein College of Medicine
Irene Soloway; BFA, RPA; Albert Einstein College of Medicine
E5 - Hepatitis C Education and Care for Veterans
Summary: This workshop will focus on education and knowledge of Hepatitis C among veterans with chronic HCV infection, including pre- and post-test results around educational classes. In addition, experience with an alcohol intervention toolkit for use in various clinic settings where veterans are seen will be presented.
Moderator: Lawrence Deyton; Public Health, US Dept. of Veterans Affairs
Demographic,
diagnostic, and health behavior correlates of HCV knowledge
regarding viral routes of transmission and disease risk factors [PDF - 28 pages]
(92)
John W. Davison; MBA, PhD; VA Puget Sound Health Care System
Improving Hepatitis C Care For Veterans: Development of a Brief
Alcohol Intervention Toolkit [PDF - 40 pages]
(93)
John W. Davison; MBA, PhD; VA Puget Sound Health Care System
Effectiveness
of a Hepatitis C group education class in Veterans Administration
treatment settings [PDF - 27 pages]
(94)
John W. Davison; MBA, PhD; VA Puget Sound Health Care System
E6 - Hepatitis Prevention for American Indian and Alaska Native Populations [PDF - 10 pages]
Summary: This workshop will focus on viral hepatitis prevention services integrated into various venues that serve Alaska Native and American Indian populations that may be at high risk for hepatitis. Counseling and testing for HCV infection, as well programs to promote vaccination and mechanisms to evaluate services will be covered.
Moderators: John Redd; IHS, DVH, CDC and Cecile M. Town; IHS, DVH, CDC
Developing Viral Hepatitis Screening and Prevention Services
for American Indians and Alaska Natives at an Urban Chemical Dependency
Treatment Facility [PDF - 32 pages] (95)
Mei Castor; MD, MPH; Urban Indian Health Institute; Seattle Indian
Health Board
Shelly Huffman; MPH; Seattle Indian Health Board
Linking Laboratory Surveillance, Primary Care Medical Programs,
And Community-Based Activities To Provide Viral Hepatitis Prevention
Programs For Higher Risk American Indian Individuals [PDF - 14 pages] (96)
Charlton Wilson; MD; Phoenix Indian Medical Center
Interior
Alaska [PDF - 12 pages]
Kathleen Cunniffe, RN
F1 - Evaluation of Perinatal HBsAg Identification Based on Universal Reporting Mechanisms
Summary: Discussion of methods to evaluate perinatal Hepatitis B prevention identification using birth certificate and newborn screening data.
Moderator: Susan Wang; DVH, CDC
Accuracy of Birth Certificate Data on Reporting Hepatitis B Screening
in Pregnant Women [PDF - 19 pages] (97)
Wendy Lee Griffin; RN, BSN, MSPH; Colorado Department of Public
Health and Environment
Evaluation of newborn screening data in Michigan [PDF - 15 pages]
Pat Fineis, Michigan Department of Community Health
Alabama’s
Retrospective Review of Births [PDF - 19 pages]
Tasneem Malik, NIP
F2 - Education and Resources for Persons Co-infected with HIV and HCV [PDF - 8 pages]
Summary: This workshop will include epidemiologic data from Michigan’s surveillance activities on estimates of HCV and HIV co-infection in the southeast part of Michigan, followed by presentation and discussion of the educational and support services that are available and should be advocated for persons with co-infection and providers who care for such persons.
Moderators: Richard Controneo, Director, HIV Education & Training Programs, NYS DOH;, Judy V. Schmidt, National Immunization Program, CDC/NIP
Hepatitis
C-HIV Co-infection in Southeast Michigan, 2000-2002 [PDF - 35 pages]
(98)
Linda L. Wotring; Ph, D, MPH; Michigan Department of Community Health
HIV/HCV Co-infection:
Treatment Can Work, Support Services Are Essential, Advocacy is
a Must! [PDF - 29 pages]
Jules Levin, Executive Director, National AIDS Treatment Advocacy
Project
F3 - Clinical and Educational Tools for Managing Chronic Hepatitis C Virus Infection
Summary: This workshop will focus on integrated clinical care for patients with chronic Hepatitis C virus infection, including vaccinating against Hepatitis A and B, screening for and managing co-morbid psychiatric conditions and substance use disorders, and providing patient education. It will also provide an overview of educational materials and products developed and available for both patients and providers by the VA Hepatitis C Resource Centers.
Moderator: Joanna Buffington; DVH, CDC
Diagnosed With Hepatitis C ? An Overview of What's Next
Peter Hauser, Portland Veterans Affairs Medical Center
Evaluating Universal Vaccination against Hepatitis A and B in
Patients with Chronic Hepatitis C (99)
Helen S. Yee; PharmD; Department of Veterans Affairs Medical Center,
San Francisco
Integrated
Care Models for HCV+ Veterans with Co-morbid Psychiatric and Substance-Use
Disorders [PDF - 90 pages]
(100)
Betsy L. Zucker; FNP; Portland Veterans Affairs Medical Center
Peter Hauser; MD; Portland Veterans Affairs Medical Center
Hepatitis C Treatment Issues: Clinical and Biological Perspectives
(101)
David W. Indest; PsyD; Portland Veterans Affairs Medical Center
Julie A. Nelligan; PhD; Portland Veterans Affairs Medical Center
F4 - Hepatitis Integration into HIV Prevention Programs for Injection Drug Users
Summary: This workshop will focus on integrating viral hepatitis prevention activities into existing HIV prevention programs that target injecting drug users.
Moderator: Walter Chow; National Center for HIV, STD & TB Prevention, CDC
Viral Hepatitis
and HIV Prevention Program Integration for Injection Drug Users [PDF - 32 pages]
(102)
Danni Lentine; MPH; CDC
Integrating
Hepatitis C into HIV Prevention for Injecting Drug Users [PDF - 15 pages]
(103)
Vicki Lynn Sickels; LMSW, CADC; The AIDS Project of Central Iowa
Incorporating
Hepatitis C Counseling and Testing into existing HIV Counseling
and Testing services among Injection Drug Users [PDF - 16 pages]
(104)
Clark S. Marshall; BS; State of California
F5 - Hepatitis Prevention and Education in Corrections: Just Do It!!
Summary: This workshop will include a variety of tools to help deliver hepatitis educational messages and vaccination services to inmates and staff in correctional settings.
Moderators: Laurie Reid; National Center for HIV, STD & TB Prevention, CDC, and Hugh Potter; National Center for HIV, STD & TB Prevention, CDC
Hep C Inside
and Out: Prevention for Inmates and Reentry Populations [PDF - 22 pages]
(105)
Kathy Jensen; MSW; Hep C Connection
Effective
Viral Hepatitis Program in Jails and Prisons [PDF - 16 pages]
(106)
Denise R. Diefenbach; MEd; Maricopa County Department of Public
Health
Hepatitis B Program for Juvenile Correctional Facilities [PDF - 27 pages]
(107)
Beatriz E. Builes; MPH; CDC
M.'Kiaira Kimathi Miriti; PhD; CDC
F6 - HRSA – Bureau of Primary Health Care and Community Health Centers
Summary: Community Health Centers funded by HRSA are a critical resource for persons who are under- or un-insured, many of whom have substantial health problems. This workshop will focus on access and delivery of both preventive and primary care services to persons at risk for viral hepatitis infections.
Moderator: Jay Anderson; Bureau of Primary Health Care, HRSA
Thursday, Dec 8
7:30 AM-8:30 AMBreakfast Panel - Developing and Implementing State Viral Hepatitis Prevention Plans [PDF - 18 pages]
Summary: Viral Hepatitis Prevention Plans play an important role in the strategy to control and prevent viral hepatitis. These plans provide the road map for prioritizing development of prevention activities, for integrating hepatitis prevention activities into existing public health programs and for obtaining resources to achieve implementation of prevention activities. The speakers in the workshop will provide information about the development and implementation of their State Viral Hepatitis Prevention Plans discuss the accomplishments to date, and the lessons learned.
Moderators: Hope King; DVH,CDC, and Dick Moyer; DVH, CDC
Iowa Department of Public Health--Viral Hepatitis Plan
Chris Taylor, Hepatitis C Coordinator, IA Dept. of Health
Massachusetts – Hepatitis C: 2001-2005 Recommendations of the
Hepatitis C Advisory Committee
Dan Church, Hepatitis C Coordinator, MA Dept of Health
New Mexico-A Vision and Strategy: Hepatitis C In New Mexico [PDF - 15 pages]
Karen Gonzales, Hepatitis C Coordinator, NM Dept of Health
Oregon Hepatitis C Strategic Plan- Recommendations of The Viral
Hepatitis Planning Group
Ann Shindo, Hepatitis C Coordinator, OR Dept of Health
PL4 - Viral Hepatitis Prevention for IDU: What is it and What Should We be Doing?
Summary: While Injection Drug Users (IDU) prevention efforts have been focused on HIV and politicized by syringe exchange, basic questions remain about effective viral hepatitis prevention and control interventions. This plenary will review epidemiologic, scientific and programmatic aspects of viral hepatitis prevention in IDU including Hepatitis C epidemiology, a framework and the underlying science for considering prevention strategies, and the components of a comprehensive prevention strategy with examples of how they are being implemented.
Moderators: T. Stephen Jones; Consultant to CDC's Divisions of Viral Hepatitis and HIV/AIDS Prevention, and Miriam Alter; Associate Director for Science, DVH, CDC
Epidemiologic
Update: Hepatitis C [PDF - 20 pages]
Miriam Alter, DVH, CDC
Framing the
Issues: Reflections on Epi, Science, Program and the Future of Viral
Hepatitis Prevention for IDU [PDF - 47 pages]
Stephen Jones
Hepatitis Prevention for IDU: What Do We Know? [PDF - 35 pages]
David Vlahov, Director, Center for Urban Epidemiologic Studies,
New York Academy of Medicine
What Should
We Be Doing? Designing and Implementing a Comprehensive Hepatitis
Prevention Strategy for IDU [PDF - 42 pages]
Guthrie Birkhead, Director, NY State AIDS Institute
Poster Session #2
A Pilot Project to Provide Hepatitis B Vaccine to Adults in the
Public Health STD Clinic Setting (65)
Julie S. Townsend; MS; Texas Department of State Health Services
Hepatitis B Vaccine Coverage among Adults Tested for HIV in the
United States (108)
Kaafee Billah; PhD; Centers for Disease Control and Prevention (CDC)
DEBI-Izing an Oregon Harm Reduction Program Targeting HIV and
HCV Prevention among People who Inject Drugs (109)
Ann Shindo; PhD; Oregon Dept. of Human Services
A Review of Hepatitis Infection in Pakistan (110)
Altaf Bosan; MD; Federal EPI Cell, National Institute of Health
Hepatitis C Risk Behaviors among STD Clinic Clients in Upstate
New York (111)
Elena M. Rizzo; MA; NYS Department of Health
Hepatitis A and Hepatitis B Vaccination in High Risk Adults:
Florida’s Experience With Integrating Services (112)
Susanne R. Crowe; MHA; State of FL Dept. of Health
Evaluation of the Florida Hepatitis and Liver Failure Prevention
and Control Program (113)
Susanne R. Crowe; MHA; State of FL Dept. of Health
Receipt of Follow-up Services among Persons with Confirmed Positive
Hepatitis C Virus Test Results: Wisconsin, 2004 (114)
Marjorie Hurie; RN, MS; State of Wisconsin
Programs (115)
Lois Carnicom; Indiana State Department of Health
Hepatitis Prevention Practices for Women in Prostitution (116)
Patti A. Buffington; MBA; Genesis House
HCV Testing Pilot: State of Connecticut Department of Public
Health Laboratory and Viral Hepatitis Program Partnership (117)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of
Public Health
HCV Outbreak at an Oncology Clinic in Fremont Nebraska (118)
Kathryn L. White; MT, RN, BSN; Nebraska HHSS
Hepatitis B Vaccination Proximate to Syringe Exchange Sites (119)
Frederick L. Altice; MD; Yale University
Testing and Counseling for Hepatitis B, Hepatitis C, and HIV
Infections in Opioid Treatment Programs (OTP’s). Summary results
from two surveys (120)
Thomas F. Kresina; PhD; NIDA, NIH, DHHS
The Gold Standard of Safer Injection: A Hepatitis Preventative
Injection: (121)
Dan Bigg; BA, CRADC; Chicago Recovery Alliance
Screening for Viral Infections (HIV, HBV, HCV) Among IDUs through
the BEAT Program: Buprenorphine Easy Access to Treatment (122)
Robert D. Bruce; MD, MA; Yale University
Hepatitis Prevention for Drug Users in Switzerland (123)
Rudolf Hotz; MSW; Swiss Office for the Reduction of Drug Related
Harm
Sexual and drug-injecting behaviors among persons with HIV infection
related to injection drug use—results from an interview project,
2000-2003 (124)
Andrew J. Mitsch; MPH; Centers for Disease Control and Prevention
Cost-Effectiveness of Testing Strategies for Chronic Hepatitis
C (125)
Michael K. Chapko; PhD; VA Puget Sound Health Care System
Hepatitis A Infection in Injection Drug Users and Homeless Persons
in Massachusetts: Responding to an Outbreak (126)
Erica Berl; DVM, MPH; Massachusetts Department of Public Health
Preliminary Results from a Hepatitis Vaccine Program Targeted
to Injection Drug Users (127)
Lauretta E. Grau; PhD; Yale School of Public Health
Prevention of Hepatitis B in a Correctional System (128)
Lester N. Wright; MD, MPH; New York State Department of Correctional
Services
Integration Across Jurisdictions: Enhanced Screening in a Rural
AI/AN Population (129)
Cecile M. Town; MPH; US Centers for Disease Control and Prevention
Integration in the Alaskan Bush: Use of Community Health Aides
to Deliver Hepatitis, STD and HIV Services (130)
Kathleen A. Cunniffe; RN, BScN, BSc, (Life, Sci; Tanana Chiefs Conference
Evaluation of Targeted Hepatitis C Virus Screening of Inmates
Admitted in 2004 to the Wisconsin Adult Correctional System (131)
Gerald Gabor; Wisconsin Immunization Program
How to Work With Your State Legislature (132)
Diane Peterson; Immunization Action Coalition
Hepatitis Prevention, Testing and Treatment in a Rural Health
Center (133)
Janet L. Soule; LPN-C; Panhandle Community Services
Challenges to Treatment of Hepatitis C in a Community Methadone
Clinic (134)
Kenneth T. Akinaka; BA; OPIVITA
The Ribavirin Pregnancy Registry (RPR) is Established (135)
Susan Sinclair Roberts; PhD; Registries and Epidemiology, Charles
River Laboratories
Perspectives on Hepatitis C Virus Epidemiology in Drug Users
(136)
Holly Hagan; MPH, PhD; National Development and Research Institutes
Hepatitis C Integration Program (137)
Rodney S. Gaither; MT, MPH, CIC; Indian Health Service
Economic Impact of an Outbreak of Acute Hepatitis B and the Need
for Adult Hepatitis Vaccine Funding (138)
Clayton K. Van Houten; MS; State of Wyoming
Integrating Perinatal Hepatitis C Prevention Activities into
Perinatal Hepatitis B Prevention Programs (139)
Patricia Raymond-Mangan; RN; RI Department of Health
A Syringe Exchange-Based Hepatitis Prevention Campaign for Injection
Drug Users in Three U.S. Cities (140)
Lauretta E. Grau; PhD; Yale School of Public Health
North Dakota Prisons Division Hepatitis Program (141)
Kathleen M. Bachmeier; Rn, BC, MS; North Dakota State Penitentiary
Building partnerships to provide prevention services in IDU populations
(142)
Cheri D. Reyes; MPH; Minnesota Department of Health Alissa Fountain;
BA; Access Works
HCV Risk Assessment and Screening in the Primary Care Office
(143)
Steven E. Szebenyi; MD, MMM; Foundation for Healthy Living
Colleen A. Flanigan; RN, MS; NYS Department of Health Sexual
Transmission of Hepatitis C Virus (HCV) among Drug Users: A Systematic
Review, 1995-2004 (144)
Salaam Semaan; DrPH; Centers for Disease Control and Prevention
Hepatitis B and Hepatitis C Coinfection with HIV/AIDS in Chicago,
Illinois (145)
Alicia M. Siston; MS, MPH; Chicago Department of Public Health
Prevention of Hepatitis B Virus (HBV) among Injection and Non-Injection
Drug users: A Systematic Review, 1995-2004 (146)
Salaam Semaan; DrPH; Centers for Disease Control and Prevention
Hepatitis C Seroconversion is Still Occurring in Veterans (147)
Kevin L. Sloan; MD; VA Puget Sound Health Care System
Lessons Learned from a Comparison of Hepatitis Pre-Screening
Protocols in Three Multiple Morbidity Mobile Testing Programs (148)
Jenny Gross; MPH, CHES; Los Angeles County, Office of AIDS Programs
and Policy
Hepatitis C Virus Infection: Survey of Screening, Evaluation
& Treatment Practices (149)
Louis Katz; MD; Scott County Health Department
Hepatitis Integration into Substance Abuse Treatment, Multiple
Level Interventions (150)
Corinna Dan; RN; Chicago Department of Public Health
Not Just the Needles: Social Networks, Social Marketing, and
Serostatus in HCV Prevention for IDUs (151)
Daniel Raymond; Harm Reduction Coalition
HCV Knowledge and Self Efficacy among Drug Treatment Program
Staff (152)
Shiela Strauss; PhD; National Development & Research Institutes
Community Partners Logic Model (153)
Julie Gleason-Comstock; PhD, CHES; Wayne State University
G1 - Viral Hepatitis Serology: Interpreting Confusing Results [PDF - 64 pages]
Summary: This workshop will provide the attendee with review of viral hepatitis serology that is out of the norm. The user will be able to work through confusing serologic results and understand why certain interpretations of these results are made. There will be a question and answer period during and at the conclusion of the workshop.
Moderator: Linda A. Moyer; DVH, CDC
H1 - Tips for Safe and Effective Hepatitis B Case Management
Summary: Field workers describe strategies for effective case management including program evaluation, cultural competency, and personal safety during site visits.
Moderator: Amy Warner; Colorado Department of Public Health and Environment
Indiana's
Perinatal Hepatitis B Prevention Program [PDF - 18 pages]
(154)
Susan E. Sparks; ASN, BGS, MAE; Indiana State Department of Health
Cultural Competency [PDF - 26 pages]
Dr. Samuel So, Asian Liver Center
Safety Issues
in the Field [PDF - 9 pages]
Chang Lee, Washington, DC STD Program
H2 - Hepatitis Education Challenges in Substance Abuse Settings
Summary: This workshop will describe some of the challenges of providing hepatitis training to staff in drug treatment programs. Successful programs and strategies for motivating staff to address viral hepatitis will be shared.
Moderator: Karen Hennessey; DVH, CDC
Critical Components
of Hepatitis Prevention Education for Health Care Providers for Substance
Users [PDF - 18 pages]
(155)
Robert D. Bruce; MD, MA; Yale University
A
Drug Treatment Program Staff Training on Hepatitis C: The Importance
of a Motivational Approach [PDF - 23 pages]
(156)
Janetta Astone-Twerell; PhD; National Development & Research Institutes
Piloting
a Staff Training on Hepatitis C at Drug Treatment Programs: Translating
Research into Practice [PDF - 23 pages]
(157)
Shiela Strauss; PhD; National Development & Research Institutes
H3 - Integration into HIV Programs: The Role of AIDS Directors and AIDS Service Organizations
Summary: Overlapping risk groups, routes of transmission, and interventions make integration of viral hepatitis prevention activities into state and community based HIV programs a natural fit yet many challenges remain. Cross-program training, planning, counseling messages, referral services, vaccination strategies, funding and evaluation are all critical programmatic issues that must be addressed before fully integrating viral hepatitis interventions into HIV programs. In this session two state AIDS Directors and a staff member from an AIDS Service Organization (ASO) will describe the challenges and successful strategies to integrating hepatitis into their AIDS programs.
Moderator: Kevin O'Connor; DVH, CDC
AIDS Directors' Experience:
Integration
of HIV, STD and Hepatitis Services [PDF - 10 pages]
(158)
Peter M. Whiticar; MA; Hawaii Department of Health
Come Together, Right Now Viral Hepatitis Integration [PDF - 24 pages]
Pat Young; Iowa Department of Health
The Role
of AIDS Service Organizations in Hepatitis Prevention [PDF - 25 pages]
(159)
Carlos Martinez; AIDS Action Committee
H4 - Chronic Hepatitis C: Access to Care for Under- and Un-Insured Patients
Summary: This workshop will offer three models for comprehensive care and treatment for patients with chronic Hepatitis C who are under- or un-insured, using primary care models.
Moderator: Thomas F. Kresina; National Institute for Drug Abuse, NIH
Taking on Hepatitis C in Maryland
Michael Rudman, Hepatitis Clinic, Frederick, MD
Taking on Hepatitis C in San Francisco
Barry Zevin, Tom Waddell Clinic, San Francisco, CA
Taking on Hepatitis C in Methadone Clients
Diana Sylvestre, OASIS, Oakland, CA
H5 - State-Wide Lessons in Integration
Summary: This workshop will include models of integrating hepatitis services in a variety of settings and through collaborations with local, state, and national partners. Experiences from New York State, Iowa, Hawaii, and New Mexico involving multiple programs within health departments and communities will be presented.
Moderator: Laurie Schowalter; National Alliance of State and Territorial AIDS Directors
Models of Viral Hepatitis Integration and Collaboration: Health
Department Perspectives (160)
Heather Lusk; BA/BS; Hawai`i Department of Health
Chris Taylor; MPH; Iowa Department of Public Health
Integration of Hepatitis Prevention & Vaccine into DEBI Interventions,
existing HIV Prevention & Harm Reduction Programs in New Mexico
(161)
Jimmy G. Schrock; BS, in, Psychology; New Mexico AIDS Services
Melissa Heinz Bennett; MPH; New Mexico Department of Health
Say It Like It's One Word: HIV/STD/Viral Hepatitis (162)
Richard Cotroneo; MA; New York State Department of Health
Dana Cropper-WIlliams; MPA, MHR; National Coalition of STD Directors
Colleen Flanigan; RN, MS; NYS Department of Health
Elizabeth Herlihy; RN, BSN, MS; New York State Department of Health
H6 - Models of Hepatitis Vaccination in Substance Abuse Treatment Settings
Summary: This workshop provides strategies used by local, state, and national-level programs to successfully integrate hepatitis vaccination services into substance abuse settings
Moderator: Judy V. Schmidt; National Immunization Program, CDC
A Pilot Hepatitis Vaccination Program For Substance Abuse Treatment
Settings (163)
Kenneth Hoffman; MD; CSAT, SAMHSA, DHHS
Developing
a Hepatitis A and B Vaccination Model within an Outpatient Opioid
Treatment Program [PDF - 13 pages]
(164)
Andrea Lombard; RN, BSN, MPH; State of Connecticut Department of
Public Health
Integrating
viral hepatitis services into residential drug treatment programs:
the Addiction Recovery Hepatitis Intervention Project [PDF - 21 pages]
(ARHIP) (165)
Andra L. Thomas; Hep-C ALERT, Inc
I1 - Hospital Based Assessment of Hepatitis B Screening of Pregnant Women
Summary: Presentation and discussion of findings of two states’ birth hospital record reviews
Moderator: Debbie Purton; Oklahoma Immunization Program
Hepatitis B Screening in Pregnant Women and Vaccine Birth Dose Administration
in Newborns: A Review from Selected Indiana Hospitals [PDF - 22 pages]
(166)
Jennifer J. McCarthy; BS; Indiana State Department of Health
Study of Hospital Perinatal Hepatitis B Prevention Practices
for Women with No Prenatal Care, California 2004 (167)
Celia Woodfill; PhD; California Department of Health Services
I2 - A Video-Based HCV Educational Curriculum for High-Risk Drug Users
Summary: A video-based HCV educational curriculum for high risk drug users will be aired, followed by discussion of the contents and how this has been, and could be used in other settings.
Moderator: Jonathan Powell; DVH, CDC
A Video-based HCV Educational Curriculum for High-Risk Drug Users
(168)
Diana L. Sylvestre; MD; O.A.S.I.S
I3 - Methamphetamine Use and Sexual Risk Behavior Among MSM [PDF - 27 pages]
Summary: Methamphetamine use is becoming increasingly common, and is contributing to increases in HIV and STD among MSM in the U.S. This workshop will include a description of the increasing methamphetamine problem, links to increasing risky sex behaviors among MSM linked to HIV and STD transmission, and discuss the potential for increases in viral hepatitis in this population. Discussion will also include the importance of increasing viral hepatitis prevention and control efforts among MSM.
Moderator: Kevin O'Connor; DVH, CDC
Addressing Methamphetamine Use and Sexual Risk Behavior
David Purcell and Gordon Mansergh, National Center for HIV, STD
& TB Prevention, CDC
I4 - Impact of Hepatitis in Frontier Settings
Summary: In this workshop, presenters will describe the impact of hepatitis on rural communities including descriptions of high risk activities that are most prevalent. The workshop will also describe interventions that have proven effective in these communities.
Moderator: Steven Wiersma; World Health Organization
Addressing
Hepatitis C in Substance Abuse Treatment in Frontier Communities [PDF - 11 pages]
(169)
Bridget Giovale; BS; Southwest Counseling Service
Hepatitis A Outbreak Among Injection Drug Users Along the Texas-Mexico
Border [PDF - 30 pages]
(170)
Gary Heseltine; MD, MPH; Texas Dept. of State Health Services
Viral Hepatitis Risks among Methamphetamine Injectors: A Qualitative
Follow up Study of an Acute Hepatitis B Outbreak (171)
Clayton K. Van Houten; MS; State of Wyoming
I5 - Implementation and Evaluation of Integrated Hepatitis Services
Summary: This workshop will include experiences from two states and a national project to evaluate the process and impact of integrating viral hepatitis prevention services into existing public health programs.
Moderator: Thomas Bertrand; STD Director, Massachusetts Dept. of Health
Evaluating the Impact of Viral Hepatitis Integration in Public
Health Settings (172)
Jennie L. Harris; MPH; RTI International
Massachusetts Viral Hepatitis Integration Program Evaluation
(173)
Daniel Church; MPH; Massachusetts Department of Public Health
Implementing Delivering and Evaluating Viral Hepatitis Services
Into Multiple STD Clinics (174)
Richard Joseph Zimmerman; MS; IL Department of Public Health
I6 - Hepatitis C Integration into Substance Abuse Treatment: Projects Supported by the Substance Abuse and Mental Health Services Administration (SAMHSA)
Summary: This workshop will showcase projects in Massachusetts, New York, and Los Angeles funded by SAMHSA to incorporate Hepatitis C training and education into substance abuse treatment programs.
Moderator: David Thompson; SAMHSA
Developing and implementing Hepatitis C training for substance abuse
treatment providers in Massachusetts [PDF - 19 pages]
MA Dept. of Public Health: Jorge Sanchez, Director of Communications,
HIV/AIDS Bureau; Carolyn Castro-Donlan, Deputy Director, Bureau
of Substance
Developing
and implementing Hepatitis C training for substance abuse treatment
providers in New York State [PDF - 11 pages]
Steven Kipnis, Medical Director, NYS Office of Alcohol and Substance
Abuse Services
Hepatitis
C curriculum for substance abuse treatment providers and staff [PDF - 22 pages]
Dan George, The Matrix Institute, Los Angeles
Friday, Dec 9
8:30 AM-10:00 AM Workshop Session JJ1 - Ask the Experts
Summary: This workshop will be a panel of viral hepatitis experts that will answer questions on viral hepatitis prevention and control. Conference attendees will have the opportunity to provide questions throughout the week and these questions and any others that attendees might have will be answered during the workshop. Questions can be about any type of viral hepatitis and can be about any topic related to viral hepatitis.
Moderator: Linda A. Moyer; CDC
Ask the Experts - Ian Williams, Eric Mast, Donna Weaver
J2 - Hepatitis on the Internet: The Good, the Bad, and the Ugly
Summary: In an era of information overload, the ability to design and identify accurate and appropriate messages and information on viral hepatitis can be a challenge. This workshop will highlight high quality reliable internet resources available to consumers and providers and describe types of misinformation most likely to be accessed by parents searching for Hepatitis B information.
Moderator: Holly R. Wilson; CDC
Interactive
Viral Hepatitis Training Website [PDF - 18 pages]
(175)
Bruce Maeder; BS; University of Washington
Internet (Mis)information
about Hepatitis B Virus (HBV) Infection and the Hepatitis B Vaccine [PDF - 64 pages]
(176)
Teresa Asper Anderson; DDS, MPH; Immunization Action Coalition
Everything You
Could Ever Want to Know About Hepatitis – The CDC Hepatitis Internet
Resource [PDF - 20 pages]
Jonathan Powell, DVH, CDC
J3 - The Changing Role of Syringe Exchange Programs in Response to Prevention of Hepatitis
Summary: In this workshop participants will learn about the history of syringe exchange programs (SEPs) in the United States including the evolution of HIV and hepatitis prevention in these programs. The workshop will describe strategies for integration of hepatitis prevention into programs that serve adults and young injectors and tell which hepatitis interventions have been most effective.
Moderator: Stephen Koester; Professor of Health & Behavioral Sciences, University of Colorado at Denver
Beyond Syringe Access: Adapting Needle Exchange Programs to HCV
Prevention [PDF - 8 pages]
(177)
Daniel Raymond; Harm Reduction Coalition
Syringe Exchange: The First 25 Years, Adapting From HIV to HBV
and HCV [PDF - 27 pages]
(178)
Don C. Des Jarlais; PhD; Beth Israel Medical Center
Drug injection initiation and Hepatitis C virus (HCV) infection:
An assessment of opportunities for intervention (179)
Lawrence J. Ouellet; PhD; University of Illinois at Chicago
J4 - HCV Testing – Laboratory Guidelines and Rapid Diagnostics
Summary: This workshop will provide a review of CDC guidelines on testing and reporting antibody to HCV; share experience on implementation of the guidelines in laboratories through experience in Florida and results of a survey of 450 laboratories; status of rapid anti-HCV assays for serum and saliva.
Moderator: Wendi Kuhnert; DVH, CDC
HCV Laboratory Testing and Result Reporting Practices: Results
of a CDC Survey
Wendi Kuhnert
Use of the Signal to Cutoff Ratio in Hepatitis C Antibody Testing
in Florida (180)
Susanne R. Crowe; MHA; State of FL Dept. of Health
Rapid HCV Diagnostics in Oral Fluid
Steven Lee, OraSure Diagnostics
J5 - Models for Hepatitis Prevention and Control for Asian/Pacific Islander Communities
Summary: Strategies to provide Hepatitis B prevention education, awareness, and services targeted to Asian Americans in California, Colorado, and New York City will be presented and discussed.
Moderator: Dolly Sinha; DVH, CDC
Jade Ribbon Campaign:
A Culturally Targeted Global Intervention to Address the High Prevalence
of Hepatitis B among Asians and Asian Americans
(181)
Samuel So; MD; Stanford University
Three For Life:
Protecting adult Asian/Pacific Islanders through hepatitis testing
and vaccination
(182)
Janet Zola; MPH; San Francisco Department of Public Health
Integration of
a Participatory Research into a Church-Based Health Survey [PDF - 43 pages]
(183)
Dr. Haoek Lee; Univ. of Colorado School of Nursing
Innovative Strategies
in Hepatitis B Prevention for Asian Americans in New York City -
A Community Health Center's Perspectives [PDF - 39 pages]
(184)
Christina Lee; BA; Charles B. Wang Community Health Center
Deborah Hong; MPA; Charles B. Wang Community Health Center
J6- Creative Approaches to Maximizing Resources
Summary: Presenters in this workshop will share experience with trying to integrate viral hepatitis prevention services into existing programs with limited resources. Federal participants will share current mechanisms for securing vaccine for use in high risk adult settings.
Moderator: Tasneem Malik; CDC/NIP
Small Budget,
Big Dreams: Missouri Hepatitis Prevention [PDF - 15 pages]
(185)
Scott Carson; MDiv; Missouri Department of Health and Senior Services
Developing HCV Infrastructure with Limited Resources [PDF - 14 pages]
(186)
Wendy Dillon; BA; Washington State Department of Health
Utilizing CDC Funding Resources
Tasneem Malik, NIP, CDC; Kevin O'Connor, DVH, CDC
PL5 - Approaches to Viral Hepatitis Prevention and Control: Legislative, Advocacy, and Community Action
Summary: This plenary will illustrate the successful implementation of various tools that state and local health departments, community-based organizations (CBOs), and other groups can adapt and use in their efforts to address hepatitis in their particular situations.
Moderator: Dan Riedford; DVH, CDC
From Liver Transplant
Surgeon to HBV and Liver Cancer Prevention Activist [PDF - 42 pages]
Samuel So; MD; Stanford University
ECHO Hepatitis C Initiative: Public Health Primary Care Collaborative
Model [PDF - 12 pages]
Michelle Lujan Grisham, NM Secretary of Health
Section 508 and Accessibility: Contact the DVH webmaster if you need help with accessibility for PDF content.
Outside CDC (
Other
Federal sites
State/Local sites
